David Gilham is the former Vice President of Research and Development and Chief Scientific Officer at Celyad, a Belgian biopharmaceutical company.
Dr. David Gilham is the former Vice President of Research and Development and Chief Scientific Officer at Celyad, a Belgian biopharmaceutical company. His expertise lies in CAR-T cells, specifically engineering T-cells for cancer therapies and preclinical study development.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide